May 31, 2017 12:33 pm UTC| Business
BRENTWOOD, Tenn. and DALLAS, May 31, 2017 -- Delek US Holdings, Inc. (NYSE:DK) (“Delek US”) and Alon USA Energy, Inc. (NYSE:ALJ) (“Alon”) today announced that, in connection with the proposed merger transaction between...
May 31, 2017 12:33 pm UTC| Business
BRENTWOOD, Tenn. and DALLAS, May 31, 2017 -- Delek US Holdings, Inc. (NYSE:DK) (“Delek US”) and Alon USA Energy, Inc. (NYSE:ALJ) (“Alon”) today announced that, in connection with the proposed merger transaction between...
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti
May 31, 2017 12:32 pm UTC| Business
SOLANA BEACH, Calif., May 31, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has entered into an agreement...
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti
May 31, 2017 12:32 pm UTC| Business
SOLANA BEACH, Calif., May 31, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has entered into an agreement...
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti
May 31, 2017 12:32 pm UTC| Business
SOLANA BEACH, Calif., May 31, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has entered into an agreement...
Syntel to Present at Investor Conference
May 31, 2017 12:31 pm UTC| Business
TROY, Mich., May 31, 2017 -- Syntel, Inc. (Nasdaq:SYNT), a leading global provider of integrated information technology and knowledge process services, today announced that the Company will present at the following...
Syntel to Present at Investor Conference
May 31, 2017 12:31 pm UTC| Business
TROY, Mich., May 31, 2017 -- Syntel, Inc. (Nasdaq:SYNT), a leading global provider of integrated information technology and knowledge process services, today announced that the Company will present at the following...